secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLIANT THERAPEUTICS, INC. (PLRX)
CIK:        0001746473
Form:       8-K
Filed at:   2026-03-30T23:59:59+00:00
Accession:  0001746473-26-000046
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Pliant Therapeutics enters $50M at-the-market equity facility with Leerink; terminates prior Cantor agreement
--------------------------------------------------------------------------------

- Entered Sales Agreement with Leerink Partners for ATM offering of common stock up to $50 million.
- Terminated 2021 Sales Agreement with Cantor Fitzgerald; no penalties incurred and no shares had been sold under it.
- New ATM program provides continued market-based equity financing flexibility.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1746473/000174647326000046/0001746473-26-000046-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1746473/000174647326000046/plrx-20260327.htm
  HTML page:      https://secwatch.observer/filing/0001746473-26-000046

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer